| Literature DB >> 31464947 |
Mei Xie1, Zhen Zhou1, Suhua Guo1, Zengqing Li1, Hui Zhao1, Jiusheng Deng2.
Abstract
RATIONALE: Angiostrongylus cantonensis-induced eosinophilic meningoencephalitis (AEM) in infants is a very rare but fatal disease. Utilization of genetic assay to detect the cerebral parasite plays an important role for the treatment of the infection. PATIENT CONCERNS: Two infants (<2 years) presented with cough, intermittent fever, mental fatigue, and poor diet. DIAGNOSIS: The patients were under clinical examination and laboratory test including cardiac ultrasound, chest X-ray, blood or cerebrospinal fluid (CSF) cell counting, serum enzyme-linked immunosorbent assay (ELISA), head magnetic resonance imaging (MRI) and next-generation sequencing (NGS) on DNA from CSF. Due to hypereosinophils in patients' peripheral blood and CSF, and abundant DNA sequences from A cantonensis in CSF, the patients were diagnosed with Angiostrongylus eosinophilic meningoencephalitis.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31464947 PMCID: PMC6736482 DOI: 10.1097/MD.0000000000016985
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Cell profile in peripheral blood and cerebrospinal fluid.
Figure 1Magnetic resonance imaging on the heads of the patients after admission. T2 FLAIR signal in the right cerebellar hemisphere (A) and signal in the bilateral occipital lobe (B) of patient 1. T2 FLAIR signal in the right cerebellar hemisphere (C) and in the bilateral occipital lobe (D) of patient 2.
Figure 2Next-generation sequencing on patients’ cerebrospinal fluid. (A) Identified DNA sequences corresponding to Angiostrongylus cantonensis in patient 1. (B) Identified DNA sequences corresponding to A cantonensis in patient 2.
Next-generation sequencing sequence reads from Angiostrongylus cantonensis on patients’ cerebrospinal fluid.
Figure 3The profile of eosinophils and white blood cell (WBC) in cerebrospinal fluid (CSF) and peripheral blood of the patients after treatment. The changes of eosinophils in CSF (A) and in peripheral blood (B) of the patients after treatment. The changes of WBC in CSF (C) and in peripheral blood (D) of the patients after treatment.
Figure 4Head magnetic resonance imaging of the patients after treatment. T2 FLAIR signal in the right cerebellar hemisphere (A) and in the bilateral occipital lobe (B) of patient 1 on day 30 after treatment. T2 FLAIR signal in the right cerebellar hemisphere (C) and in the bilateral occipital lobe (D) of patient 2 on day 30 after treatment.